MQ Health - Macquarie University

Melanoma research and precision cancer therapy

The Precision Cancer Therapy Laboratory in MQ Health explores the oncogenic (or cancer-causing) signals that drive the growth of tumours, particularly from melanoma. This helps identify and understand the mechanisms by which sub-populations of melanoma cells evolve and evade current therapies.

Recognising that, even within a single patient, tumours have diverse molecular profiles (i.e. genes and proteins), this research is identifying ways to refine single or combined therapies to best treat those specific molecular profiles in individual melanoma patients.

This work is done collaboratively with Melanoma Institute Australia, and is supported by a range of funding including a Macquarie-led $14.5M Program Grant from the National Health and Medical Research Council.